Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
We aimed to analyze the serum levels of cytokines that have relevance to the pathologies including, interleukin-4 (IL-4), transforming growth factor-β (TGF-β), interferon-γ (IFN-γ), and IL-6 cytokines of overweight men with DM and/or hypertension.
|
30260038 |
2019 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
On the other hand, significant elevations of serum Reg2 antibody and splenic CD4+/IFN-γ+ T cells, and decreases in serum IL-4 and IL-10 were detected in rReg2-vaccinated mice, which may contribute to the accelerated diabetes.
|
30690849 |
2019 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Depletion of the hyperglycemic response in the case of low alcohol consumption in DM rats was associated with elevated plasma cytokines, especially IL-6 and IL-4, which could be a part of a host defense mechanism to repair the hepatic and pancreatic damage through this inflammatory process.
|
30170484 |
2019 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Only two haplotypes (A1) & (A2) of IL-4 (VNTR) gene were recognized among Egyptian population; (A2) allele may influence in diabetes but not its complication (neuropathy) among Egyptian diabetic patients.
|
30318704 |
2018 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, three analytes were associated with obesity independently of diabetes: interleukin 4, soluble CD40 ligand, and chemokine (C-C motif) ligand 3.
|
28840653 |
2017 |
Diabetes Mellitus
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Induction of diabetes by streptozotocin was associated with reduction of body weight and insulin level, increase in glucose level and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), and reduction in IL-2 and IL-4 levels.
|
28142150 |
2017 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, IFN-tau inhibited the development of diabetes in the NOD.IL4(null) but not the NOD.IFN-gamma(null) mice, suggesting a coordinated interaction between type I and type II IFNs to suppress diabetes development.
|
26716812 |
2016 |
Diabetes Mellitus
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Rats were studied 30 days after the STZ treatment, and the diabetes untreated model group presented significantly higher kidney index, blood glucose, triglyceride (TG), total cholesterol (TC), malondialdehyde (MDA), interferon-γ (IFN-γ), and IFN-γ/IL-4 levels, lower body weight, fasting blood insulin (FPI), IL-4, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and nitric oxide (NO) levels and worse renal function (higher blood urea nitrogen (BUN), serum creatinine (SCr), urine protein (UP) levels and glomerular extracellular matrix (relative area)) compared with the normal control group (p < 0.05).
|
24595557 |
2014 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
PHA-stimulated lymphocytes from children with diabetes also produced more IL-4 and purified protein derivative (PPD)-stimulated lymphocytes less TGF-beta than lymphocytes from autoantibody-negative control children.
|
16879245 |
2006 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Protection from diabetes was associated with a biased IL-4-secreting cytokine phenotype of NKT cells and alteration of the cytokine microenvironment in the pancreatic lymph nodes of transgenic mice.
|
15128771 |
2004 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Both IL-4 and hGAD65 plant tissue were required to protect nonobese diabetic mice from diabetes, and no benefit was found if either was used alone.
|
15056761 |
2004 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
LHGDN |
Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos.
|
12748907 |
2003 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
A critical role of IL-4 for the Ag-specific protective effect triggered by plasmid administration was revealed in female IL-4(-/-) NOD mice that developed diabetes and higher Th1 responses.
|
11509644 |
2001 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Means by which IL-4 directed signals could indirectly alter diabetes susceptibility are proposed.
|
10674354 |
2000 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
Increased mRNA expression for IFN-gamma and/or IL-4 could be observed in lymphocytes from 13/16 children with recent onset of diabetes after in vitro stimulation with the ABBOS-peptide.
|
10741569 |
2000 |
Diabetes Mellitus
|
0.100 |
AlteredExpression
|
group |
BEFREE |
This pseudo-IL-4 activity was found in a subset of control subjects, patients with type 1A diabetes, and their relatives and was primarily associated with specific HLA alleles protective for type 1A diabetes (e.g., DQB1*0602).
|
10535450 |
1999 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
IL-4 production by PBMC or T cells was strongly impaired in IDDM patients at diabetes onset (p < 0.0001).
|
8906850 |
1996 |